Want to join the conversation?
$VRSN ended 1Q16 with cash, cash equivalents and marketable securities of $1.9Bil, a decrease of $20MM from year-end 2015. Cash flow from operations was $144MM for 1Q16 compared with $133MM for 1Q15. Deferred revenues on March 31, 2016 totaled $992MM, an increase of $31MM from year-end 2015.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.